We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO International ConventionJune 3-6, 2019
BIO World Congress on Industrial Biotechnology and Ag TechJuly 8-11, 2019
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
February 11 - 12, 2019 | New York, New York
Dr. Anil Diwan is President and Chairman of NanoViricides, Inc. He began working in nanomedicines ca. 1992. He invented "TheraCour®" technologies at AllExcel, Inc., a private company he founded. The TheraCour technologies form the basis of the nanoviricides® platform. Dr. Diwan co-founded NanoViricides, Inc. which became public through a reverse shell merger in 2005, and he led its up-listing to NYSE-AMER. exchange in September 2013. Dr. Diwan played a key role in developing a multi-product cGMP-capable R&D API facility which was later purchased at cost by NanoViricides, Inc. He is intimately involved in drug development activities from design to drug product. Prior to founding AllExcel, Inc., Dr. Diwan performed post-doctoral research in Virology at Univ. of Connecticut, Storrs. Before that, he did post-doctoral research in Biomedical Engg. at Univ. of Wisconsin, Madison. He holds a PhD in (Bio)Chem. Engg. from Rice Univ., Houston, TX, and a BTech (Chem Engg.) from IIT Bombay.
This speaker's sessions: